Cargando…
Spasticity in multiple sclerosis and role of glatiramer acetate treatment
INTRODUCTION: Spasticity is one of the most disabling and difficult-to-treat symptoms shown by patients with multiple sclerosis, who often show a suboptimal and unsatisfactory response to classic treatment and new available nonpharmacological alternatives. Due to the progressive nature of this condi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589813/ https://www.ncbi.nlm.nih.gov/pubmed/26445705 http://dx.doi.org/10.1002/brb3.367 |